IL82420A0 - Method of detecting aids virus infection - Google Patents

Method of detecting aids virus infection

Info

Publication number
IL82420A0
IL82420A0 IL82420A IL8242087A IL82420A0 IL 82420 A0 IL82420 A0 IL 82420A0 IL 82420 A IL82420 A IL 82420A IL 8242087 A IL8242087 A IL 8242087A IL 82420 A0 IL82420 A0 IL 82420A0
Authority
IL
Israel
Prior art keywords
virus infection
aids virus
detecting aids
detecting
infection
Prior art date
Application number
IL82420A
Other languages
English (en)
Original Assignee
Epitope Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/860,169 external-priority patent/US4917998A/en
Application filed by Epitope Inc filed Critical Epitope Inc
Publication of IL82420A0 publication Critical patent/IL82420A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL82420A 1986-05-06 1987-05-05 Method of detecting aids virus infection IL82420A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/860,169 US4917998A (en) 1986-05-06 1986-05-06 Method of detecting AIDS virus infection
US06/877,609 US4904581A (en) 1986-05-06 1986-06-23 Method of detecting AIDS virus infection

Publications (1)

Publication Number Publication Date
IL82420A0 true IL82420A0 (en) 1987-11-30

Family

ID=27127559

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82420A IL82420A0 (en) 1986-05-06 1987-05-05 Method of detecting aids virus infection

Country Status (7)

Country Link
US (1) US4904581A (da)
EP (1) EP0248534A3 (da)
AU (1) AU7250887A (da)
DK (1) DK229587A (da)
FI (1) FI871982A7 (da)
IL (1) IL82420A0 (da)
NO (1) NO871862L (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
AU616897B2 (en) * 1987-07-31 1991-11-14 Japan Immuno Research Laboratories Co., Ltd. Detection method of abnormally-responding lymphocytes as well as detection reagent and kit therefor
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
DE3804148A1 (de) * 1988-02-11 1989-08-24 Andreas Dr Plueckthun Verfahren zur spaltung von fusionsproteinen
IL89584A (en) * 1988-03-15 1994-05-30 Us Commerce Focal immunoassay of hiv and hiv infected cells
AU608413B2 (en) * 1988-03-30 1991-03-28 Abbott Laboratories Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
CA1335880C (en) * 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
AU642171B2 (en) * 1989-10-05 1993-10-14 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Monoclonal antibodies to segments of HIV-1 reverse transcriptase
WO1991007493A1 (en) * 1989-11-13 1991-05-30 Xoma Corporation Chimeric mouse human antibodies with specificity to hiv antigens
CA2044627A1 (en) * 1989-11-13 1991-05-14 Randy R. Robinson Chimeric mouse human antibodies with specificity to hiv antigens
ATE155583T1 (de) * 1991-03-06 1997-08-15 Ortho Diagnostic Systems Inc Denaturierte transportproteine zur verbesserung von enzymgebundenen immunoassays (elisa)
US20030118985A1 (en) * 1997-05-14 2003-06-26 Hunt Jeffrey C. Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136798A3 (en) * 1983-08-25 1986-02-19 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
IE58321B1 (en) * 1984-04-23 1993-09-08 Us Health Isolation of proteins of HTLV-III, serological detection of antibodies to HTLV-III in sera of patients with aids and pre-aids conditions, and detection of HTLV-III infection bi/immuno-assays using HTLV-III infection by immuno-assays using HTLV-III and its proteins
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE3690028C2 (de) * 1985-01-15 1995-05-24 Cancer Res Inst Verfahren und Testkit für die Analyse einer biologischen Probe auf Antikörper gegen Retroviren
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Also Published As

Publication number Publication date
EP0248534A3 (en) 1989-05-03
FI871982A0 (fi) 1987-05-05
EP0248534A2 (en) 1987-12-09
DK229587A (da) 1987-11-07
AU7250887A (en) 1987-11-12
DK229587D0 (da) 1987-05-05
NO871862L (no) 1987-11-09
FI871982A7 (fi) 1987-11-07
US4904581A (en) 1990-02-27
NO871862D0 (no) 1987-05-05

Similar Documents

Publication Publication Date Title
LTIP1794A (en) Method for the production of an aids virus vaccine
YU165486A (en) Process for obtaining vaccine against aids
ZA876706B (en) Method of discrimination detection using two frequencies
IL82420A0 (en) Method of detecting aids virus infection
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
PH24087A (en) Method of inhibiting the transmission of aids virus
PT83682B (en) Process for the expression of an aids virus gene
ZA903258B (en) Method of suppressing hiv infection
GB8614733D0 (en) Aids treatment
RU1785659C (ru) Cпocoб oпpeдeлehия pecпиpatopho-cиhциtиaльhoй bиpуchoй иhфekции
RU1785660C (ru) Cпocoб oпpeдeлehия pecпиpatopho-cиhциtиaльhoй bиpуchoй иhфekции
CS527587A2 (en) Method of 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine preparation
AU1668788A (en) Method of vaccination for hepatitis b virus
AU6332286A (en) A method of detecting infectious aids virus
IL91807A0 (en) Method of detecting a human b-lymphotropic virus infection
GB8707708D0 (en) Detection & treatment of aids
GB8602815D0 (en) Detecting infection
IE862908L (en) Aids virus gene expression
RU1785657C (ru) Cпocoб bыяbлehия bиpуca лacca
SU1374783A1 (ru) Cпocoб oбhapужehия mиkoплaзmehhыx зapaжehий
GB8609671D0 (en) Detection of bacteria
ZA889498B (en) Method of inhibiting virus
ZA889496B (en) Method of inhibiting virus
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
GB8629748D0 (en) Detection of diseases